Novalix Belgium SRL
36.3 FTENovalix Belgium reported total assets of €1.64m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 36.3 full-time equivalents.
By total assets for 2025, Novalix Belgium ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Novalix Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -25 % Headcount (avg FTE) +14 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novalix Belgium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 12 Dec 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
Novalix Belgium's financial analysis
- Solvency11.9%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novalix Belgium
Novalix Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0784.616.271
- VAT number
- BE0784616271
- Peppol
- Registered · 0208:0784616271 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Apr 2022
- Registered office
- 1420 Braine-l'Alleud
- Size
- Small · 36.3 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Novalix Belgium (SRL) has been based in Braine-l'Alleud since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 238,895 € and equity of 194,823 €; its revenue is not published. With 36.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 11.9%, below the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Novalix Belgium
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Matthys Charlotte Research and experimental development on natural sciences and engineering Aalter · balance sheet €1.65m
- E-Proteins Research and experimental development on natural sciences and engineering Gembloux · balance sheet €1.71m
- Trim Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.50m
- Otorino Research and experimental development on natural sciences and engineering Waterloo · balance sheet €1.86m
- Eilc Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €1.32m
- ReWind Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €2.09m
- Apotheker-Bioloog Dimitri Baetens Research and experimental development on natural sciences and engineering Lokeren · balance sheet €2.15m
Frequently asked questions about Novalix Belgium
What is the revenue of Novalix Belgium?
Novalix Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Novalix Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0784616271 for Novalix Belgium, if the company is VAT-registered. Its company number (CBE) is 0784.616.271.
Where is the registered office of Novalix Belgium?
According to the CBE register, the registered office of Novalix Belgium is in 1420 Braine-l'Alleud.
What is the equity of Novalix Belgium?
At the close of the 2025 financial year, the equity of Novalix Belgium amounts to 194,823 €, a solvency of 11.9% of total assets.
How many people work at Novalix Belgium?
36.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Novalix Belgium?
The register lists 2 active mandates at Novalix Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Novalix Belgium within its sector?
By total assets for 2025, Novalix Belgium ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Novalix Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →